Identifying cancer origin using circulating tumor cells

Molecular detection and prognostic value of epithelial markers mRNA expression in peripheral blood of advanced non-small cell lung cancer patients

(2017) Oscar Arrieta et al.   Cancer Biomarkers

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cytokeratin 20 improves the detection of circulating tumor cells in patients with colorectal cancer

(2015) Charlotte Welinder et al.   CANCER LETTERS

Cytokeratin-20 and Survivin-Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR Approach

(2015) Y. Ning et al.   MOLECULAR CANCER THERAPEUTICS

Efficient elusion of viable adhesive cells from a microfluidic system by air foam

(2014) Jr-Ming Lai et al.   Biomicrofluidics

Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis

(2014) Nicola Aceto et al.   CELL

Antibody conjugated supported lipid bilayer for capturing and purification of viable tumor cells in blood for subsequent cell culture

(2013) Jen-Chia Wu et al.   BIOMATERIALS

A negative selection system PowerMag for effective leukocyte depletion and enhanced detection of EpCAM positive and negative circulating tumor cells

(2013) Hung-Chih Lin et al.   CLINICA CHIMICA ACTA

The utility of PSMA and PSA immunohistochemistry in the cytologic diagnosis of metastatic prostate carcinoma

(2013) Kurt D. Bernacki et al.   DIAGNOSTIC CYTOPATHOLOGY

Paired diagnostic and pharmacodynamic analysis of rare non-small cell lung cancer cells enabled by the VerIFAST platform

(2013) Benjamin P. Casavant et al.   LAB ON A CHIP

Circulating tumor cells: Advances in isolation and analysis, and challenges for clinical applications

(2013) Ramdane Harouaka et al.   PHARMACOLOGY & THERAPEUTICS

Heterogeneity of Estrogen Receptor Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients

(2013) Anna Babayan et al.   PLoS One

Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer

(2012) Jian-Mei Hou et al.   JOURNAL OF CLINICAL ONCOLOGY

Cytokeratin Expression Profiling in Gastric Carcinoma: Clinicopathologic Significance and Comparison with Tumor-Associated Molecules

(2012) Hokuto Takami et al.   PATHOBIOLOGY

Functional Characterization of Circulating Tumor Cells with a Prostate-Cancer-Specific Microfluidic Device

(2012) Brian J. Kirby et al.   PLoS One

Mechanisms of confluence-dependent expression of CD26 in colon cancer cell lines

(2011) Masako Abe et al.   BMC CANCER

Clinical significance of CDX2-positive circulating tumour cells in colorectal cancer patients

(2011) S C C Wong et al.   BRITISH JOURNAL OF CANCER

Circulating tumor cells: approaches to isolation and characterization

(2011) Min Yu et al.   JOURNAL OF CELL BIOLOGY

Thyroid transcription factor-1 expression in colorectal adenocarcinomas

(2011) Matthias Dettmer et al.   PATHOLOGY RESEARCH AND PRACTICE

Prostate-specific antigen and hormone receptor expression in male and female breast carcinoma

(2010) Teresa S Kraus et al.   Diagnostic Pathology

High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer

(2010) Sarah Minner et al.   PROSTATE

Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate Cancer

(2010) S. L. Stott et al.   Science Translational Medicine

CK7, CK20, CDX2 and MUC2 Immunohistochemical Staining Used To Distinguish Metastatic Colorectal Carcinoma Involving Ovary from Primary Ovarian Mucinous Adenocarcinoma

(2009) J. H. Shin et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Cancer micrometastases

(2009) Klaus Pantel et al.   Nature Reviews Clinical Oncology

Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1

(2009) Carol W. M. Chan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA